I am keeping an eye on BMEA, which I wrote about when it had its GLB in late March. It seems impervious to the market’s weakness–great relative strength.
Blog Post: $LLY rockets higher to ATH after retesting GLB, see daily chart
Three days after the GLB the stock returned to kiss the green line. Note the huge volume Wednesday as LLY announced promising clinical trial results.